The FDA's assessment of two drugs for chronic weight management

MeSH terms

• Abnormalities, Drug-Induced
• Anti-Obesity Agents / adverse effects
• Anti-Obesity Agents / therapeutic use*
• Benzazepines / therapeutic use*
• Delayed-Action Preparations
• Drug Approval*
• Drug Combinations
• Female
• Fructose / adverse effects
• Fructose / analogs & derivatives*
• Fructose / therapeutic use
• Humans
• Obesity / drug therapy*
• Phentermine / therapeutic use*
• Pregnancy
• Serotonin Receptor Agonists / therapeutic use
• Topiramate
• United States
• United States Food and Drug Administration
• Weight Loss / drug effects